FORTE Updates - April 2024

April 10 2024

FORTE enrolled its 1300th participant on March 8, 2024, exactly one month after accruing its 1200th! We are also well on our way to 1400 participants!

FORTE Workshop at #NRG2024  

The FORTE Workshop was held on Friday, February 16, where Dr. Bruner, NCORP Contact PI, championed the importance of this colorectal cancer prevention clinical trial. Topics discussed include an overview of the trial’s progress and protocol practices for FORTE success (Dr. Robert Schoen, Protocol Chair), discussing FORTE with gastroenterologists (Dr. Jeffrey Dueker, Protocol Co-Chair), FORTE enrollment at Kaiser Permanente Northern California (Jasmine Deras), and promoting FORTE within your clinical research network (Cheryl Leow, FORTE Education and Communication Specialist). The FORTE Workshop included a vibrant Q&A session, with engaged discussion with sites at different activation and accrual levels. Watch the FORTE Workshop recording to review these topics and more.

Accrual Updates and Milestones (as of March 31, 2024) 

Top accruing sites:

Kaiser Permanente – Vallejo – 799 accrued
UPMC-Presbyterian Hospital – 203 accrued
Regions Hospital – 73 accrued

Most recent randomizations: 
Stanford Cancer Institute Palo Alto – March 28, 2024
Kaiser Permanente-San Diego Zion – March 28, 2024
Veterans Administration Hospital – March 28, 2024
Minneapolis VA Medical Center – March 28, 2024
UPMC-Presbyterian Hospital – March 28, 2024

Most trial-wide monthly accrual: 
January 2024 – 69 participants
February 2024 – 85 participants
March 2024 – 115 participants

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:

1(800) 477-7227 

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.